Delivery Order 36F79722D0161-36C26024F0050
Award Date
11/1/23
Potential Completion Date
10/31/24
Potential Value
$185K
Federal Agency
Veterans Integrated Service Network 20
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Amneal Pharmaceuticals Of New York, LLC (doing business as Amneal Pharmaceuticals) for the supply of XYREM (sodium oxybate) oral solution. The $173,571.00 contract, issued under the GSA Multiple Award Schedule for Pharmaceuticals and Drugs, has an ultimate completion date of October 31, 2025. Amneal, a for-profit limited liability company that manufactures pharmaceuticals and drugs, has also been...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded Jazz Pharmaceuticals, Inc. a $738,222.53 delivery order against the company's Pharmaceuticals and Drugs GSA Schedule contract. The firm fixed price order is for the delivery of sodium oxybate (Xyrem) 500mg/ml solution and calcium/magnesium/potassium/sodium oxybate to the VA. Performance will take place in Palo Alto, California over one year beginning November 1, 2021 through October...
This is a federal contract award to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of the oral medication Xyrem, a specialty pharmaceutical product used to treat sleep disorders. The award is under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to efficiently procure needed medications for its medical facilities nationwide. The contract is a...
This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, to provide the specialty medication Xyrem. The $53,357.40 firm fixed price delivery order was placed under Jazz Pharmaceuticals' $150 million Blanket Purchase Agreement and $116 million Federal Supply Schedule contract for the Pharmaceuticals and Drugs product category. The contract supports the VA's provision of healthcare services...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs National Acquisition Center to Amneal Pharmaceuticals Of New York, LLC, doing business as Amneal Pharmaceuticals. The $153,826 contract is for the bulk delivery of pharmaceuticals under the agency's Pharm Repackaging Program. The award is not set aside for any small business categories. Amneal Pharmaceuticals is a for-profit limited liability company that manufactures and supplies pharmaceuticals and drugs to...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Jazz Pharmaceuticals, Inc. a $10,671.48 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) to provide XYREM 500 MG. The firm fixed price order is for delivery of the specified pharmaceutical product to a location in St. Louis, Missouri by March 31, 2023. No set-aside provisions were applied to this order placed under the GSA...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc. to provide specialty pharmaceutical products, including Xyrem, Xywav, and sodium oxybate, to VA medical facilities. The contract is a Blanket Purchase Agreement (BPA) call order under Jazz Pharmaceuticals' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The potential value of this particular call order is...
This is a delivery order contract awarded by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract, valued at $92,126.70, is for the delivery of specialty pharmaceuticals such as Xyrem, Xywav, and sodium oxybate formulations to VA medical facilities across the country. The contract has a period of performance through January 31, 2018 and is a firm...
This is a delivery order awarded by the Veterans Health Administration (VHA) to Jazz Pharmaceuticals, Inc., a global biopharmaceutical company, for the specialty pharmaceutical Xyrem. The $21,714.82 firm fixed price contract was issued under Jazz Pharmaceuticals' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which allows the VHA to efficiently procure needed medications. This delivery order supports healthcare services for veterans at VHA facilities...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded a $49,921 firm fixed price blanket purchase agreement call contract to Jazz Pharmaceuticals, Inc. to supply pharmacy ordering services for XYREM prescriptions. The contract was awarded utilizing Jazz Pharmaceutical's Pharmaceuticals and Drugs GSA Schedule, which allows federal agencies to place orders for pharmaceutical products and related services. Performance will take place in Palo...